Immupharma

IMM · AIM · Health Care · mcap £21m · 4.0p

Beta Briefing, track record and bull & bear case are not ready for Immupharma yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 51 companies are already wired into a briefing: browse them.

Lanstead Capital Investors LP 6 Oct – 10 Sep · 4 notices

9.0% → 14.7%

share price at the notices 3.5–11.1p · now 4.0p 6 Oct 2025 4 Nov 2025 10 Apr 2026 10 Sep 2026

Luca & Associates AG 6 Jan · 1 notice

4.4% → 2.8%

share price at the notices 6.9p · now 4.0p 6 Jan 2026

Directors

No open-market share purchases by directors in 12 months.

other ImmuPharma PLC announced the immediate appointment of Ketan Patel as an independent Non-Executive Director to its board. Patel brings extensive expertise in financial markets, with a focus on the UK healthcare and life s 13 Oct 2025

Company filings. Not investment advice.